| Biocon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532523 |
NSE Symbol : BIOCON |
P/E(TTM) : 393.52 |
|
ISIN Demat : INE376G01013 |
Div & Yield% : 0.12 |
EPS(TTM) : 1.08 |
|
Book Value(₹) : 167.99 |
Market Cap(₹Cr) : 69,262.00 |
Face Value(₹) : 5.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,346.40 | 2,242.60 | 2,127.30 | 1,992.90 | 1,738.20 |
| Other Income | 319.70 | 849.80 | 207.50 | 3,134.20 | 187.20 |
| Stock Adjustments | 118.70 | 54.60 | 99.10 | -3.20 | 105.80 |
| Total Income | 2,784.80 | 3,147.00 | 2,433.90 | 5,123.90 | 2,031.20 |
| EXPENDITURE : | |||||
| Raw Materials | 1,187.60 | 1,085.40 | 1,033.80 | 981.00 | 914.00 |
| Power and Fuel Cost | 215.80 | 192.00 | 215.30 | 279.20 | 231.00 |
| Other Manufacturing Expenses | 165.90 | 150.70 | 155.40 | 127.10 | 130.50 |
| Selling and Administration Expenses | 193.20 | 172.00 | 135.00 | 112.20 | 106.70 |
| Miscellaneous Expenses | 224.40 | 20.00 | -28.10 | 32.90 | 33.00 |
| Employee Benefit Expenses | 467.20 | 501.30 | 452.30 | 433.80 | 367.70 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 330.70 | 1,025.60 | 470.20 | 3,157.70 | 248.30 |
| Interest | 142.40 | 236.90 | 198.80 | 69.60 | 0.40 |
| Gross Profit | 188.30 | 788.70 | 271.40 | 3,088.10 | 247.90 |
| Depreciation | 137.30 | 127.80 | 121.10 | 116.90 | 108.20 |
| Profit Before Tax | 51.00 | 660.90 | 150.30 | 2,971.20 | 139.70 |
| Current Tax | 12.00 | 30.60 | 15.10 | 132.70 | 60.70 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.80 | 21.00 | 15.90 | -9.90 | -7.10 |
| Reported Net Profit | 37.20 | 609.30 | 119.30 | 2,848.40 | 86.10 |
| Extraordinary Items | -138.10 | 660.11 | 13.41 | 2,861.73 | 2.92 |
| Adjusted Net Profit | 175.30 | -50.81 | 105.89 | -13.33 | 83.18 |
| Adjustment below Net Profit | -23.50 | -1.30 | 30.70 | 29.40 | -59.40 |
| Profit/Loss Balance carried down | 10,468.50 | 9,920.50 | 9,950.60 | 7,132.80 | 7,106.10 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 66.80 | 60.00 | 180.10 | 60.00 | 0.00 |
| P & L Balance carried down | 10,415.40 | 10,468.50 | 9,920.50 | 9,950.60 | 7,132.80 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 30.00 | 10.00 |
| Dividend Per Share(Rs) | 0.50 | 0.50 | 0.50 | 1.50 | 0.50 |
| Earnings Per Share-Unit Curr | 0.23 | 5.07 | 0.99 | 23.72 | 0.72 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 166.85 | 96.63 | 90.88 | 90.91 | 67.40 |
| Book Value(Adj)-Unit Curr | 166.85 | 96.63 | 90.88 | 90.91 | 67.40 |
